Wemade Max (101730) 2026 stock outlook. A KOSDAQ game publisher and Wemade subsidiary levered to its parent's new titles, the Mir IP franchise, and the WEMIX blockchain platform — with a deep look at earnings volatility, parent risk, and small-cap liquidity.
Philoptics (161580) 2026 stock outlook. A deep qualitative look at three growth legs — display laser cutting, EV battery notching, and glass substrate (TGV) equipment — plus the equipment-vendor earnings swings, Samsung customer concentration, and capex-cycle leverage that define the stock.
DMS (Digital Manufacturing System, 068790) 2026 stock outlook. A deep qualitative look at its display and semiconductor wet-process equipment business, dependence on Chinese panel capex, the LCD-to-OLED transition, and its push to diversify into solar and battery equipment.
GST Global Standard Technology (KOSDAQ 083450) stock outlook for 2026. A deep look at the moat of a Korean niche supplier that builds both semiconductor process chillers and gas scrubbers, its sensitivity to front-end capex cycles, the environmental-regulation tailwind, and the customer-concentration and small-cap volatility risks.
A practical 2026 guide to the QSBS Section 1202 capital-gains exclusion: C-corp and original-issue rules, the gross-assets cap, the five-year holding period, qualified trades, the greater of $10M or 10x basis exclusion, the 2025 OBBBA tiered changes, stacking, Section 1045 rollovers, and the mistakes that blow it up.
A 2026 guide to DSCR loans for rental and investment property in the US: how the debt service coverage ratio is calculated, qualification requirements (credit, LTV, cash flow, no personal income docs), typical rate ranges, pros and cons versus a conventional mortgage, and the pitfalls that quietly eat your returns.
A working owner's guide to pest control business insurance cost in 2026 — general liability, pollution and chemical-applicator liability, workers' comp, commercial auto, tools coverage, real cost ranges, the drivers that move your premium, and how to cut it.
A plain-English breakdown of plumber insurance cost in 2026 — general liability, workers' comp, commercial auto, tools and equipment coverage, surety bonds, and BOP price ranges, plus the drivers that move your premium and how to pay less.
A practical 2026 guide to the social media addiction lawsuits against Meta, TikTok, Snap, and YouTube — the MDL 3047 and California JCCP proceedings, who may qualify (teens, parents, school districts), what plaintiffs must prove, and how any settlement would likely be structured.
How the paraquat Parkinson's disease lawsuit works in 2026 — MDL 3004 status in Illinois, who qualifies, how settlement amounts are estimated by severity, exposure and occupation, and the mistakes that sink claims.
OHI (Omega Healthcare Investors) 2026 stock outlook. A deep, qualitative look at this skilled-nursing and senior-housing net-lease healthcare REIT: the high dividend, operator credit risk, Medicaid reimbursement and labor costs, rent coverage, and how it stacks up against peers.
PRGS Progress Software stock outlook for 2026: how the OpenEdge-to-ShareFile infrastructure roll-up mints maintenance cash flow, funds its dividend and buybacks, and carries the unresolved MOVEit breach litigation as its defining tail risk.
ICUI (ICU Medical) 2026 stock outlook. A qualitative deep dive into the installed-base and recurring-consumables moat, the three-player US IV fluids oligopoly, the debt and margin overhang from the Smiths Medical acquisition, and hospital capex cyclicality for US investors.
GSHD (Goosehead Insurance) 2026 stock outlook. A deep look at the personal-lines franchise brokerage model, the renewal-royalty recurring-revenue moat, sensitivity to home sales and the hard insurance market, a premium growth valuation, and the metrics that actually matter each quarter.
SWX (Southwest Gas Holdings) 2026 stock outlook. A grounded look at the Arizona and Nevada regulated gas utility's rate-base growth model, rate-case regulatory risk, interest-rate-sensitive valuation, the Centuri (CTRI) spin-off and residual stake, the dividend, and the Carl Icahn activist history.
Matson (NYSE: MATX) 2026 stock outlook — how the protected Jones Act Hawaii, Alaska, and Guam trade lanes anchor a steady earnings floor while the volatile China CLX expedited service drives the boom-bust cycle, plus the buyback engine, key risks, a peer table, and metrics that actually matter.
MSA Safety (NYSE MSA) 2026 stock outlook. A qualitative deep dive into its gas detection, SCBA breathing apparatus, fire helmets and fall protection lines, the OSHA and NFPA regulation that manufactures non-discretionary replacement demand, fire-service and industrial capex exposure, the competitive field, valuation, and how US investors should frame the position.
CENT (Central Garden and Pet) 2026 stock outlook. A deep qualitative look at the pet-and-garden brand roll-up model, retailer concentration and private-label pressure, garden seasonality and weather risk, M&A integration, and the CENT versus CENTA dual-share structure for US investors.
Cal-Maine Foods (CALM) 2026 stock outlook. A deep, qualitative read on America's largest egg producer: bird-flu supply shocks, the wholesale egg-price cycle, cage-free capex, the one-third-of-earnings variable dividend, and the slow pivot toward specialty eggs and prepared foods.
PTLO (Portillo's) 2026 stock outlook. A grounded look at industry-leading average unit volumes, the Italian beef and Chicago-dog cult brand moat, Sun Belt unit expansion economics, debt and the tax receivable agreement, and why the stock has lagged since its IPO.
Sajo Seafood (KOSPI 014710) 2026 stock outlook. A deep qualitative read on its place inside Sajo Group's vertical integration, the tuna cost cycle driven by skipjack prices, bunker fuel and the won-dollar rate, domestic seafood demand, and the asset-value-versus-governance discount.
Innowireless (KOSDAQ 073490) 2026 stock outlook. A deep qualitative look at its 5G wireless test-and-measurement moat, small-cell and positioning businesses, the telecom capex cycle, the 6G catalyst, overseas-operator demand swings, and the risks of owning a small-cap cyclical.
Samil Pharmaceutical (KOSPI 000520) 2026 stock outlook. A deep qualitative look at the Korean ophthalmic eye-drop franchise, the large sterile-ophthalmic CDMO plant in India, the operating leverage tied to plant utilization, the upfront capital burden, and what US investors should watch on tax and currency.
Dasan Networks (KOSDAQ 039560) 2026 stock outlook. A deep qualitative look at its switch and PON fiber-access hardware business, US and Japan export exposure, currency leverage, dependence on carrier capex cycles, the DZS (former Dasan Zhone) relationship risk, and how it stacks up against Korean peers.